Pascal Heitel

575 total citations
17 papers, 439 citations indexed

About

Pascal Heitel is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Pascal Heitel has authored 17 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Pharmacology and 5 papers in Oncology. Recurrent topics in Pascal Heitel's work include Peroxisome Proliferator-Activated Receptors (6 papers), Drug Transport and Resistance Mechanisms (4 papers) and Estrogen and related hormone effects (3 papers). Pascal Heitel is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (6 papers), Drug Transport and Resistance Mechanisms (4 papers) and Estrogen and related hormone effects (3 papers). Pascal Heitel collaborates with scholars based in Germany, Sweden and Italy. Pascal Heitel's co-authors include Daniel Merk, Ewgenij Proschak, Astrid Kaiser, Jan Heering, Jurema Schmidt, Manfred Schubert‐Zsilavecz, Mario Wurglics, A. Chaikuad, Stefan Knapp and Astrid S. Kahnt and has published in prestigious journals such as Journal of the American Chemical Society, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Pascal Heitel

17 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascal Heitel Germany 13 243 96 79 74 71 17 439
Matthias Gabler Germany 10 212 0.9× 61 0.6× 45 0.6× 89 1.2× 27 0.4× 14 374
Paul K. Spearing United States 9 208 0.9× 154 1.6× 121 1.5× 76 1.0× 47 0.7× 16 559
Alfred Binggeli Switzerland 10 325 1.3× 102 1.1× 58 0.7× 102 1.4× 15 0.2× 10 509
Harilal Patel India 13 202 0.8× 67 0.7× 27 0.3× 25 0.3× 19 0.3× 46 512
Lamees Hegazy United States 13 191 0.8× 128 1.3× 32 0.4× 35 0.5× 20 0.3× 28 421
Alan D. Adams United States 14 483 2.0× 104 1.1× 39 0.5× 35 0.5× 36 0.5× 16 766
Emiliano Rosatelli Italy 10 170 0.7× 101 1.1× 26 0.3× 24 0.3× 47 0.7× 13 486
Jih‐Lie Tseng United States 13 248 1.0× 63 0.7× 27 0.3× 18 0.2× 63 0.9× 26 569
Shengrong Li China 15 344 1.4× 125 1.3× 48 0.6× 21 0.3× 10 0.1× 58 597
Henrietta Dehmlow Switzerland 15 621 2.6× 197 2.1× 22 0.3× 84 1.1× 36 0.5× 21 969

Countries citing papers authored by Pascal Heitel

Since Specialization
Citations

This map shows the geographic impact of Pascal Heitel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Heitel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Heitel more than expected).

Fields of papers citing papers by Pascal Heitel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Heitel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Heitel. The network helps show where Pascal Heitel may publish in the future.

Co-authorship network of co-authors of Pascal Heitel

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Heitel. A scholar is included among the top collaborators of Pascal Heitel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Heitel. Pascal Heitel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Heitel, Pascal. (2023). Emerging TACnology: Heterobifunctional Small Molecule Inducers of Targeted Posttranslational Protein Modifications. Molecules. 28(2). 690–690. 12 indexed citations
3.
Marschner, Julian A., Pascal Heitel, Astrid Kaiser, et al.. (2023). Targeting the Alternative Vitamin E Metabolite Binding Site Enables Noncanonical PPARγ Modulation. Journal of the American Chemical Society. 145(27). 14802–14810. 22 indexed citations
4.
Liu, Jianyang, Raj Kumar Singh, Maria Ekoff, et al.. (2022). Biosynthesis of prostaglandin 15dPGJ2 -glutathione and 15dPGJ2-cysteine conjugates in macrophages and mast cells via MGST3. Journal of Lipid Research. 63(12). 100310–100310. 9 indexed citations
5.
Ni, Xiaomin, A. Chaikuad, Sridhar Sreeramulu, et al.. (2021). The Transcriptional Repressor Orphan Nuclear Receptor TLX Is Responsive to Xanthines. ACS Pharmacology & Translational Science. 4(6). 1794–1807. 12 indexed citations
6.
Heitel, Pascal, Jurema Schmidt, Astrid Kaiser, et al.. (2020). A triple farnesoid X receptor and peroxisome proliferator-activated receptor α/δ activator reverses hepatic fibrosis in diet-induced NASH in mice. Communications Chemistry. 3(1). 174–174. 14 indexed citations
7.
Heitel, Pascal, Jan Heering, Astrid S. Kahnt, et al.. (2020). l-Thyroxin and the Nonclassical Thyroid Hormone TETRAC Are Potent Activators of PPARγ. Journal of Medicinal Chemistry. 63(13). 6727–6740. 41 indexed citations
8.
Neumann, Sebastian, et al.. (2020). Design and Structural Optimization of Dual FXR/PPARδ Activators. Journal of Medicinal Chemistry. 63(15). 8369–8379. 23 indexed citations
9.
Heitel, Pascal, et al.. (2019). Computer-Assisted Discovery and Structural Optimization of a Novel Retinoid X Receptor Agonist Chemotype. ACS Medicinal Chemistry Letters. 10(2). 203–208. 37 indexed citations
10.
Schmidt, Jurema, M. Hartmann, Astrid Kaiser, et al.. (2019). Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from Zafirlukast. ChemMedChem. 15(1). 50–67. 16 indexed citations
11.
Kaiser, Astrid, et al.. (2019). A Novel Biphenyl-based Chemotype of Retinoid X Receptor Ligands Enables Subtype and Heterodimer Preferences. ACS Medicinal Chemistry Letters. 10(9). 1346–1352. 14 indexed citations
12.
Heitel, Pascal, Jan Heering, Astrid S. Kahnt, et al.. (2018). Urate transporter inhibitor lesinurad is a selective peroxisome proliferator-activated receptor gamma modulator (sPPARγM) in vitro. Scientific Reports. 8(1). 13554–13554. 14 indexed citations
13.
Heitel, Pascal, Sabine Willems, Jurema Schmidt, et al.. (2018). Boosting Anti-Inflammatory Potency of Zafirlukast by Designed Polypharmacology. Journal of Medicinal Chemistry. 61(13). 5758–5764. 30 indexed citations
14.
Heitel, Pascal, et al.. (2017). DrugBank screening revealed alitretinoin and bexarotene as liver X receptor modulators. Bioorganic & Medicinal Chemistry Letters. 27(5). 1193–1198. 41 indexed citations
15.
Proschak, Ewgenij, et al.. (2017). Opportunities and Challenges for Fatty Acid Mimetics in Drug Discovery. Journal of Medicinal Chemistry. 60(13). 5235–5266. 75 indexed citations
16.
Schmidt, Jurema, Matthias Gabler, Pascal Heitel, et al.. (2017). Nonacidic Farnesoid X Receptor Modulators. Journal of Medicinal Chemistry. 60(16). 7199–7205. 70 indexed citations
17.
Heitel, Pascal, et al.. (2014). Benchmark of electronic structure methods for protein–ligand interactions based on high-level reference data. Journal of Theoretical and Computational Chemistry. 14(1). 1540001–1540001. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026